ATE541575T1 - Brausetabletten, enthaltend alendronat - Google Patents

Brausetabletten, enthaltend alendronat

Info

Publication number
ATE541575T1
ATE541575T1 AT03716287T AT03716287T ATE541575T1 AT E541575 T1 ATE541575 T1 AT E541575T1 AT 03716287 T AT03716287 T AT 03716287T AT 03716287 T AT03716287 T AT 03716287T AT E541575 T1 ATE541575 T1 AT E541575T1
Authority
AT
Austria
Prior art keywords
tablets containing
effervescent tablets
containing alendronate
effervescent
alendronate
Prior art date
Application number
AT03716287T
Other languages
English (en)
Inventor
David Mccallister
Christer Rosen
Original Assignee
Effrx Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effrx Pharmaceuticals Sa filed Critical Effrx Pharmaceuticals Sa
Application granted granted Critical
Publication of ATE541575T1 publication Critical patent/ATE541575T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03716287T 2002-03-06 2003-03-06 Brausetabletten, enthaltend alendronat ATE541575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9208302A 2002-03-06 2002-03-06
PCT/US2003/006576 WO2003075884A1 (en) 2002-03-06 2003-03-06 Effervescent compositions comprising bisphosphonates and methods related thereto

Publications (1)

Publication Number Publication Date
ATE541575T1 true ATE541575T1 (de) 2012-02-15

Family

ID=27804153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03716287T ATE541575T1 (de) 2002-03-06 2003-03-06 Brausetabletten, enthaltend alendronat

Country Status (8)

Country Link
US (1) US20060240103A1 (de)
EP (2) EP2277503B1 (de)
AT (1) ATE541575T1 (de)
AU (1) AU2003219999A1 (de)
CA (1) CA2495886C (de)
DK (1) DK1490024T3 (de)
ES (2) ES2448501T3 (de)
WO (1) WO2003075884A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
NZ555725A (en) * 2004-11-23 2008-07-31 Dong Wha Pharmaceuticals Ind C N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methansulfonic acid salt
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
FR2952815B1 (fr) 2009-11-25 2012-01-06 Oreal Produit cosmetique
WO2011130440A1 (en) * 2010-04-13 2011-10-20 Amerilab Technologies, Inc. Effervescent tablets comprising an oil component
KR102011505B1 (ko) * 2010-12-06 2019-08-16 에프락스 파머슈티컬즈 소시에떼 아노님 신속한 용해 특성을 구비한 안정한 발포성 비스포스포네이트 제형
JP6566450B2 (ja) 2014-09-17 2019-08-28 ステアライフ・インディア・プライベート・リミテッド 発泡組成物及びそれを製造する方法
MX2017006052A (es) * 2014-11-17 2017-09-01 Kraft Foods Group Brands Llc Bebida con tartrato de sodio y potasio.
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN106924257B (zh) * 2017-03-14 2019-11-19 湖南赛隆药业有限公司 质子泵抑制剂和抗骨质疏松药的复合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5858146A (ja) 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
IT1195993B (it) * 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
US4687662A (en) 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
US4710384A (en) 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DE59201238D1 (de) 1991-07-01 1995-03-02 Gerhard Gergely Reaktionsdotierte brausesysteme.
EP0521388B1 (de) * 1991-07-01 1995-05-10 Gerhard Dr. Gergely Verfahren zur Herstellung einer pharmazeutischen Zubereitung mit wenigstens zwei verschiedenen Wirkstoffen und Verwendung einer solchen Zubereitung
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
US5639475A (en) 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5853759A (en) 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
CA2254060C (en) * 1996-05-17 2007-05-01 Merck & Co., Inc. Effervescent bisphosphonate formulation
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6015801A (en) 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
IT1293764B1 (it) 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
BR0016058A (pt) * 1999-12-03 2003-07-15 Univ California San Diego Compostos de fosfonato
JP2001253827A (ja) 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法

Also Published As

Publication number Publication date
ES2380924T3 (es) 2012-05-21
DK1490024T3 (da) 2012-04-10
EP1490024B1 (de) 2012-01-18
WO2003075884A1 (en) 2003-09-18
CA2495886A1 (en) 2004-09-18
EP2277503A1 (de) 2011-01-26
AU2003219999A1 (en) 2003-09-22
EP1490024A1 (de) 2004-12-29
US20060240103A1 (en) 2006-10-26
EP2277503B1 (de) 2014-02-12
ES2448501T3 (es) 2014-03-14
CA2495886C (en) 2011-05-03

Similar Documents

Publication Publication Date Title
WO2004035004A3 (en) Effervescent compositions comprising bisphosphonates and methods related thereto
ATE541575T1 (de) Brausetabletten, enthaltend alendronat
ATE481105T1 (de) Wässrige zusammensetzungen mit metronidazol
ATE506950T1 (de) Zusammensetzungen enthaltend metronidazol
GB0201866D0 (en) Method and compositions for disinfecting hard surfaces
EP1365290A4 (de) Resistzusammensetzung
DE60222293D1 (de) Härtbare harzzusammensetzung
AU2003298532A8 (en) Grating-stabilized semiconductor laser
NO20053545D0 (no) Bindingsmidler som inhiberer myostatin.
DK1047406T3 (da) Autoklaverbar farmaceutisk sammensætning indeholdende en chelatdanner
DK1718677T3 (da) Monovalente antistoffragmenter egnede som terapeutiske midler
EP1446460A4 (de) Kupferhaltiges wässriges reinigungsmittel sowie spezieller korrosionsinhibitor zur abreinigung von anorganischen resten von halbleitersubstrat
ECSP034600A (es) Compuestos de lactama
EP1446114A4 (de) Zusammensetzungen und verfahren zur behandlung von osteoporose
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
EP1577992A4 (de) Halbleiterlaserbaugruppe
SG123557A1 (en) Chemical amplified photoresist compositions
PL1735369T3 (pl) Polidiorganosiloksany ulegające szybkiemu utwardzaniu
HUP0400004A2 (hu) Oxálsavat tartalmazó peszticid készítmények
SG102072A1 (en) Polymer for chemical amplified photoresist compositions
ATE369139T1 (de) Hochdosierte ibandronat-formulierung
GB0323962D0 (en) Lipid profile modulation
EP1179749B8 (de) Resistzusammensetzung und Verfahren zur Herstellung von Halbleiterbauelementen
EP1426394A4 (de) Harzzusammensetzung zur verkapselung von optischen halbleitern
AU2003251680A8 (en) Semiconductor laser device